LIGAND PHARMACEUTICALS INC (LGND) › Cost of RevenueLIGAND PHARMACEUTICALS INC (LGND) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2016: $5.57M2017: $5.37M2018: $6.34M$6.34M2016Cost of Revenue (USD)2018Fiscal YearCost of RevenueChange YoY2018$6.34M+18.1%2017$5.37M-3.7%2016$5.57M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share